Table 6.

Univariable analysis for the prediction of pathologic upstaging in potential active surveillance patients

Predictors of upstaging	Univariable analyses
	OR	95% CI on OR	P value	PA; %
Preop PSA (continuous)	1.12	0.92, 1.35	0.2611	55.6
Clinical stage (t2 vs. t1)	2.06	0.47, 9.16	0.3410	51.7
Biopsy cores (≥18 vs. <18)	0.90	0.27, 3.07	0.8698	50.5
Positive cores (2 vs. 1)	2.07	0.98, 4.36	0.0556	58.6
Max % Bx (>5% vs. ≤5%)	1.29	0.61, 2.72	0.5034	53.2
HGPIN Bx (yes vs. no)	1.24	0.42, 3.66	0.6951	51.2
Prostate volume (continuous)	0.98	0.96, 1.00	0.0799	59.5

PA predictive accuracy (AUC from c-statistic)